{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T20:27:58Z","timestamp":1648758478276},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:00:00Z","timestamp":1534204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11926-018-0768-7","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T08:22:43Z","timestamp":1534234963000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rheumatic Manifestations of Haemoglobinopathies"],"prefix":"10.1007","volume":"20","author":[{"given":"Michael","family":"Hughes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,14]]},"reference":[{"key":"768_CR1","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/rheumatology\/kew042","volume":"55","author":"M Hughes","year":"2016","unstructured":"\u2022\u2022 Hughes M, Akram Q, Rees DC, Peter Jones AK. Haemoglobinopathies and the rheumatologist. Rheumatology (Oxford). 2016;55:2109\u2013211. Our previous review examining the rheumatic\/MSK manifestations in the haemoglobinopathies which contains historical\/legacy studies","journal-title":"Rheumatology (Oxford)"},{"key":"768_CR2","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","volume":"376","author":"DC Rees","year":"2010","unstructured":"Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376:2018\u201331.","journal-title":"Lancet"},{"key":"768_CR3","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Piel FB, Steinberg MH, Rees DC. Sickle cell disease. Longo DL, editor. N Engl J Med 2017;376:1561\u201373. A recent review in NEJM written by experts on SCD.","DOI":"10.1056\/NEJMra1510865"},{"key":"768_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/ncomms1104","volume":"1","author":"FB Piel","year":"2010","unstructured":"Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Williams TN, et al. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun. 2010;1:104.","journal-title":"Nat Commun"},{"key":"768_CR5","unstructured":"Origa R. Beta-thalassemia. In: Adam MP, Ardinger HH, Pagon, et al., editors. GeneReviews\u00ae [Internet]. Seattle: University of Washington, Seattle; 1993\u20132018. Available from: \n                      https:\/\/www.ncbi.nlm.nih.gov\/sites\/books\/NBK1426\/"},{"key":"768_CR6","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/rheumatology\/kev360","volume":"55","author":"SA Morais","year":"2016","unstructured":"\u2022\u2022 Morais SA, du Preez HE, Akhtar MR, Cross S, Isenberg DA. Musculoskeletal complications of haematological disease. Rheumatology (Oxford). 2016;55:968\u201381. A review examining the MSK complications of haematological disease.","journal-title":"Rheumatology (Oxford)"},{"key":"768_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/rheumatology\/kex058","volume":"57","author":"MHA Noureldine","year":"2018","unstructured":"\u2022\u2022 Noureldine MHA, Taher AT, Haydar AA, Berjawi A, Khamashta MA, Uthman I. Rheumatological complications of beta-thalassaemia: an overview. Rheumatology (Oxford). 2018;57:19\u201327. A review examining the rheumatological complications of beta-thalassaemia.","journal-title":"Rheumatology (Oxford)"},{"key":"768_CR8","doi-asserted-by":"publisher","first-page":"20160130","DOI":"10.1259\/bjr.20160130","volume":"90","author":"V Kosaraju","year":"2017","unstructured":"\u2022 Kosaraju V, Harwani A, Partovi S, Bhojwani N, Garg V, Ayyappan S, et al. Imaging of musculoskeletal manifestations in sickle cell disease patients. Br J Radiol. 2017;90:20160130. A well-illustrated review detailing imaging of the MSK manifestations in patients with SCD.","journal-title":"Br J Radiol"},{"key":"768_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejrnm.2011.12.005","volume":"43","author":"SA Khedr","year":"2012","unstructured":"Khedr SA, Hassaan MA, Shabana AA, Gaballah AH, Mokhtar DA. Musculoskeletal manifestations of sickle cell disease, diagnosis with whole body MRI. Egypt J Radiol Nucl Med. 2012;43:77\u201384.","journal-title":"Egypt J Radiol Nucl Med"},{"key":"768_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJM199107043250103","volume":"325","author":"OS Platt","year":"1991","unstructured":"Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325:11\u20136.","journal-title":"N Engl J Med"},{"key":"768_CR11","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/RHU.0000000000000326","volume":"21","author":"MHK Leung","year":"2015","unstructured":"Leung MHK, Hughes M, Lane J, Basu S, Ryan K, Jones AKP. Severe disability in a patient with rheumatoid arthritis and sickle cell anemia: an underreported, but yet a potentially treatable combination of diseases. J Clin Rheumatol. 2015;21:458\u20139.","journal-title":"J Clin Rheumatol"},{"key":"768_CR12","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1148\/rg.274065142","volume":"27","author":"VC Ejindu","year":"2007","unstructured":"Ejindu VC, Hine AL, Mashayekhi M, Shorvon PJ, Misra RR. Musculoskeletal manifestations of sickle cell disease. Radiographics. 2007;27:1005\u201321.","journal-title":"Radiographics"},{"key":"768_CR13","doi-asserted-by":"crossref","unstructured":"Ganguly A, Boswell W, Aniq H. Musculoskeletal manifestations of sickle cell anaemia: A pictorial review. Anemia. 2011;2011.","DOI":"10.1155\/2011\/794283"},{"key":"768_CR14","first-page":"107","volume":"70","author":"J Bahebeck","year":"2004","unstructured":"Bahebeck J, Atangana R, Techa A, Monny-Lobe M, Sosso M, Hoffmeyer P. Relative rates and features of musculoskeletal complications in adult sicklers. Acta Orthop Belg. 2004;70:107\u201311.","journal-title":"Acta Orthop Belg"},{"key":"768_CR15","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1365-2141.2005.05476.x","volume":"129","author":"A Almeida","year":"2005","unstructured":"Almeida A, Roberts I. Bone involvement in sickle cell disease. Br J Haematol. 2005;129:482\u201390.","journal-title":"Br J Haematol"},{"key":"768_CR16","doi-asserted-by":"publisher","first-page":"564","DOI":"10.4103\/2141-9248.122110","volume":"3","author":"J Chinawa","year":"2013","unstructured":"Chinawa J, Chukwu B, Ikefuna A, Emodi I. Musculoskeletal complications among children with sickle cell admitted in university of Nigeria teaching hospital ituku - Ozalla Enugu: a 58 month review. Ann Med Health Sci Res. 2013;3:564\u20137.","journal-title":"Ann Med Health Sci Res"},{"key":"768_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.2106\/00004623-200303000-00016","volume":"85\u2013A","author":"P Hernigou","year":"2003","unstructured":"Hernigou P, Bachir D, Galacteros F. The natural history of symptomatic osteonecrosis in adults with sickle-cell disease. J Bone Joint Surg Am. 2003;85\u2013A:500\u20134.","journal-title":"J Bone Joint Surg Am"},{"key":"768_CR18","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/S0009-9260(99)91081-4","volume":"54","author":"MM Booz","year":"1999","unstructured":"Booz MM, Hariharan V, Aradi AJ, Malki AA. The value of ultrasound and aspiration in differentiating vaso-occlusive crisis and osteomyelitis in sickle cell disease patients. Clin Radiol. 1999;54:636\u20139.","journal-title":"Clin Radiol"},{"key":"768_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1053\/crad.1999.0377","volume":"55","author":"RR William","year":"2000","unstructured":"William RR, Hussein SS, Jeans WD, Wali YA, Lamki ZA. A prospective study of soft-tissue ultrasonography in sickle cell disease patients with suspected osteomyelitis. Clin Radiol. 2000;55:307\u201310.","journal-title":"Clin Radiol"},{"key":"768_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0730-725X(99)00137-X","volume":"18","author":"H Umans","year":"2000","unstructured":"Umans H, Haramati N, Flusser G. The diagnostic role of gadolinium enhanced MRI in distinguishing between acute medullary bone infarct and osteomyelitis. Magn Reson Imaging. 2000;18:255\u201362.","journal-title":"Magn Reson Imaging"},{"key":"768_CR21","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.2106\/00004623-200112000-00007","volume":"83\u2013A","author":"DL Skaggs","year":"2001","unstructured":"Skaggs DL, Kim SK, Greene NW, Harris D, Miller JH. Differentiation between bone infarction and acute osteomyelitis in children with sickle-cell disease with use of sequential radionuclide bone-marrow and bone scans. J Bone Joint Surg Am. 2001;83\u2013A:1810\u20133.","journal-title":"J Bone Joint Surg Am"},{"key":"768_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1365-2141.2006.06035.x","volume":"133","author":"MJH Witjes","year":"2006","unstructured":"Witjes MJH, Berghuis-Bergsma N, Phan TTH. Positron emission tomography scans for distinguishing between osteomyelitis and infarction in sickle cell disease. Br J Haematol. 2006;133:212\u20134.","journal-title":"Br J Haematol"},{"key":"768_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.crad.2007.07.017","volume":"63","author":"R Jain","year":"2008","unstructured":"Jain R, Sawhney S, Rizvi SG. Acute bone crises in sickle cell disease: the T1 fat-saturated sequence in differentiation of acute bone infarcts from acute osteomyelitis. Clin Radiol. 2008;63:59\u201370.","journal-title":"Clin Radiol"},{"key":"768_CR24","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1007\/s11999-009-1149-3","volume":"468","author":"P Hernigou","year":"2010","unstructured":"Hernigou P, Daltro G, Flouzat-Lachaniette C-H, Roussignol X, Poignard A. Septic arthritis in adults with sickle cell disease often is associated with osteomyelitis or osteonecrosis. Clin Orthop Relat Res. 2010;468:1676\u201381.","journal-title":"Clin Orthop Relat Res"},{"key":"768_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/rheumatology\/26.2.99","volume":"26","author":"WW Ebong","year":"1987","unstructured":"Ebong WW. Septic arthritis in patients with sickle-cell disease. Br J Rheumatol. 1987;26:99\u2013102.","journal-title":"Br J Rheumatol"},{"key":"768_CR26","unstructured":"\u2022\u2022 Rees D. Haemoglobinopathies. In: Watts R, Conaghan P, Denton C, Foster H, Isaacs J, M\u00fcller-Ladner U, editors. Oxford Textbook of Rheumatology. 2013. p. 1466\u201370. A comprehensive overview of the rheumatological manifestations seen in the haemoglobinopathies."},{"key":"768_CR27","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.2106\/JBJS.E.01455","volume":"88","author":"P Hernigou","year":"2006","unstructured":"Hernigou P, Habibi A, Bachir D, Galacteros F. The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease. J Bone Joint Surg Am. 2006;88:2565\u201372.","journal-title":"J Bone Joint Surg Am"},{"key":"768_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.arth.2017.09.010","volume":"33","author":"I Ilyas","year":"2018","unstructured":"\u2022 Ilyas I, Alrumaih HA, Rabbani S. Noncemented total hip arthroplasty in sickle-cell disease: long-term results. J Arthroplasty. 2018;33:477\u201381. A retrospective study which showed good long-term survival of the hip prosthesis at 10\u00a0years in patients with SCD who received hip arthroplasty for AVN.","journal-title":"J Arthroplasty"},{"key":"768_CR29","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/j.1365-2141.2006.06487.x","volume":"136","author":"M Sarrai","year":"2007","unstructured":"Sarrai M, Duroseau H, D\u2019Augustine J, Moktan S, Bellevue R. Bone mass density in adults with sickle cell disease. Br J Haematol. 2007;136:666\u201372.","journal-title":"Br J Haematol"},{"key":"768_CR30","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00198-013-2454-y","volume":"25","author":"P Wong","year":"2014","unstructured":"Wong P, Fuller PJ, Gillespie MT, Kartsogiannis V, Milat F, Bowden DK, et al. The effect of gonadal status on body composition and bone mineral density in transfusion-dependent thalassemia. Osteoporos Int. 2014;25:597\u2013604.","journal-title":"Osteoporos Int"},{"key":"768_CR31","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/ajh.20541","volume":"81","author":"RG Miller","year":"2006","unstructured":"Miller RG, Segal JB, Ashar BH, Leung S, Ahmed S, Siddique S, et al. High prevalence and correlates of low bone mineral density in young adults with sickle cell disease. Am J Hematol. 2006;81:236\u201341.","journal-title":"Am J Hematol"},{"key":"768_CR32","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00277-017-2959-0","volume":"96","author":"M Baldini","year":"2017","unstructured":"Baldini M, Marcon A, Ulivieri FM, Seghezzi S, Cassin R, Messina C, et al. Bone quality in beta-thalassemia intermedia: relationships with bone quantity and endocrine and hematologic variables. Ann Hematol. 2017;96:995\u20131003.","journal-title":"Ann Hematol"},{"key":"768_CR33","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1007\/s00198-016-3719-z","volume":"27","author":"AD Dede","year":"2016","unstructured":"\u2022 Dede AD, Trovas G, Chronopoulos E, Triantafyllopoulos IK, Dontas I, Papaioannou N, et al. Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease. Osteoporos Int. 2016;27:3409\u201325. A good review including an overview of treatment for thalassemia-associated osteoporosis.","journal-title":"Osteoporos Int"},{"key":"768_CR34","doi-asserted-by":"publisher","first-page":"546","DOI":"10.4103\/2230-8210.137516","volume":"18","author":"MA Yassin","year":"2014","unstructured":"Yassin MA, Soliman AT, De Sanctis V, Abdelrahman MO, Aziz Bedair EM, AbdelGawad M. Effects of the anti-receptor activator of nuclear factor kappa B ligand denusomab on beta thalassemia major-induced osteoporosis. Indian J Endocrinol Metab. 2014 Jul;18:546\u201351.","journal-title":"Indian J Endocrinol Metab"},{"key":"768_CR35","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00774-015-0689-8","volume":"34","author":"N Morabito","year":"2016","unstructured":"Morabito N, Catalano A, Gaudio A, Morini E, Bruno LM, Basile G, et al. Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis. J Bone Miner Metab. 2016;34:540\u20136.","journal-title":"J Bone Miner Metab"},{"key":"768_CR36","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1111\/trf.13237","volume":"55","author":"S Tournis","year":"2015","unstructured":"Tournis S, Dede AD, Savvidis C, Triantafyllopoulos IK, Kattamis A, Papaioannou N. Effects of teriparatide retreatment in a patient with \u03b2-thalassemia major. Transfusion. 2015;55:2905\u201310.","journal-title":"Transfusion"},{"key":"768_CR37","first-page":"CD010429","volume":"3","author":"A Bhardwaj","year":"2016","unstructured":"\u2022 Bhardwaj A, Swe KMM, Sinha NK, Osunkwo I. Treatment for osteoporosis in people with \u00df-thalassaemia. Cochrane Database Syst Rev. 2016;3:CD010429. A Cochrane review of the treatment of osteoporosis in patients with \u00df-thalassaemia.","journal-title":"Cochrane Database Syst Rev"},{"key":"768_CR38","doi-asserted-by":"publisher","first-page":"e0119908","DOI":"10.1371\/journal.pone.0119908","volume":"10","author":"VG Nolan","year":"2015","unstructured":"Nolan VG, Nottage KA, Cole EW, Hankins JS, Gurney JG. Prevalence of vitamin D deficiency in sickle cell disease: a systematic review. PLoS One. 2015;10:e0119908.","journal-title":"PLoS One"},{"key":"768_CR39","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/pbc.25399","volume":"62","author":"MT Lee","year":"2015","unstructured":"Lee MT, Licursi M, McMahon DJ. Vitamin D deficiency and acute vaso-occlusive complications in children with sickle cell disease. Pediatr Blood Cancer. 2015;62:643\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"768_CR40","first-page":"CD010858","volume":"1","author":"HHK Soe","year":"2017","unstructured":"\u2022 Soe HHK, Abas AB, Than NN, Ni H, Singh J, Said ARBM, et al. Vitamin D supplementation for sickle cell disease. Cochrane Database Syst Rev. 2017;1:CD010858. A Cochrane review of vitamin D supplementation for SCD.","journal-title":"Cochrane Database Syst Rev"},{"key":"768_CR41","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/bjh.13433","volume":"171","author":"S Gupta","year":"2015","unstructured":"\u2022 Gupta S, Yui JC, Xu D, Fitzhugh CD, Clark C, Siddiqui S, et al. Gout and sickle cell disease: not all pain is sickle cell pain. Br J Haematol. 2015;171:872\u20135. A study examining the co-existence of gout in patients with SCD.","journal-title":"Br J Haematol"},{"key":"768_CR42","doi-asserted-by":"publisher","unstructured":"McFarlane IM, Ozeri DJ, Saperstein Y, Alvarez MR, Leon SZ, Koci K, et al. Rheumatoid arthritis in sickle-cell population: pathophysiologic insights, clinical evaluation and management. Rheumatology (Sunnyvale) 2017;7. \n                      https:\/\/doi.org\/10.4172\/2161-1149.1000225\n                      \n                    .","DOI":"10.4172\/2161-1149.1000225"},{"key":"768_CR43","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/rheumatology\/38.10.1021","volume":"38","author":"C Montecucco","year":"1999","unstructured":"Montecucco C, Caporali R, Rossi S, Epis O. Rheumatoid arthritis in beta-thalassaemia trait. Rheumatology (Oxford). 1999;38:1021\u20132.","journal-title":"Rheumatology (Oxford)"},{"key":"768_CR44","first-page":"2125","volume":"28","author":"K Nistala","year":"2001","unstructured":"Nistala K, Murray KJ. Co-existent sickle cell disease and juvenile rheumatoid arthritis. Two cases with delayed diagnosis and severe destructive arthropathy. J Rheumatol. 2001;28:2125\u20138.","journal-title":"J Rheumatol"},{"issue":"nov28 1","key":"768_CR45","first-page":"bcr1020114889","volume":"2011","author":"O. Adelowo","year":"2011","unstructured":"Adelowo O, Edunjobi AS. Juvenile idiopathic arthritis coexisting with sickle cell disease: two case reports. Case Reports 2011;2011:bcr1020114889-bcr1020114889.","journal-title":"Case Reports"},{"key":"768_CR46","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1007\/s00296-011-2125-2","volume":"32","author":"XI Pliakou","year":"2012","unstructured":"Pliakou XI, Koutsouka FP, Damigos D, Bourantas KL, Briasoulis EC, Voulgari PV. Rheumatoid arthritis in patients with hemoglobinopathies. Rheumatol Int. 2012;32:2889\u201392.","journal-title":"Rheumatol Int"},{"key":"768_CR47","doi-asserted-by":"publisher","unstructured":"McFarlane IM, Ozeri DJ, Pathiparampil J, Sanchez R, Levinson J, Campbell OB, et al. Prevalence and clinical characteristics of rheumatoid arthritis in an inner city population with sickle cell disease. J Anc Dis Prev Remedies 2017. \n                      https:\/\/doi.org\/10.4172\/2329-8731.1000218\n                      \n                    .","DOI":"10.4172\/2329-8731.1000218"},{"key":"768_CR48","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/art.1780380219","volume":"38","author":"D Mann","year":"1995","unstructured":"Mann D, Schumacher HR. Pseudoseptic inflammatory knee effusion caused by phagocytosis of sickled erythrocytes after fracture into the knee joint. Arthritis Rheum. 1995;38:284\u20137.","journal-title":"Arthritis Rheum"},{"key":"768_CR49","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/art.1780300916","volume":"30","author":"DD Gladman","year":"1987","unstructured":"Gladman DD, Bombardier C. Sickle cell crisis following intraarticular steroid therapy for rheumatoid arthritis. Arthritis Rheum. 1987;30:1065\u20138.","journal-title":"Arthritis Rheum"},{"key":"768_CR50","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/S0027-9684(15)31410-3","volume":"100","author":"DS Darbari","year":"2008","unstructured":"Darbari DS, Castro O, Taylor JG, Fasano R, Rehm J, Gordeuk VR, et al. Severe vaso-occlusive episodes associated with use of systemic corticosteroids in patients with sickle cell disease. J Natl Med Assoc. 2008;100:948\u201351.","journal-title":"J Natl Med Assoc"},{"key":"768_CR51","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3324\/haematol.10800","volume":"92","author":"S Couillard","year":"2007","unstructured":"Couillard S, Benkerrou M, Girot R, Brousse V, Ferster A, Bader-Meunier B. Steroid treatment in children with sickle-cell disease. Haematologica. 2007;92:425\u20136.","journal-title":"Haematologica"},{"key":"768_CR52","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2214\/ajr.183.4.1830989","volume":"183","author":"CJ Kellenberger","year":"2004","unstructured":"Kellenberger CJ, Schmugge M, Saurenmann T, Di Gennaro L, Eber SW, Willi UV, et al. Radiographic and MRI features of deferiprone-related arthropathy of the knees in patients with beta-thalassemia. AJR Am J Roentgenol. 2004;183:989\u201394.","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"768_CR53","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s10067-008-0969-y","volume":"27","author":"E Vlachaki","year":"2008","unstructured":"Vlachaki E, Tselios K, Perifanis V, Tsatra I, Tsayas I. Deferiprone-related arthropathy of the knee in a thalassemic patient: report of a case and review of the literature. Clin Rheumatol. 2008;27(11):1459\u201361.","journal-title":"Clin Rheumatol"},{"key":"768_CR54","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1259\/bjr.72.853.10341683","volume":"72","author":"PS Sidhu","year":"1999","unstructured":"Sidhu PS, Rich PM. Sonographic detection and characterization of musculoskeletal and subcutaneous tissue abnormalities in sickle cell disease. Br J Radiol. 1999;72:9\u201317.","journal-title":"Br J Radiol"},{"key":"768_CR55","doi-asserted-by":"crossref","unstructured":"Tageja N, Racovan M, Valent J, Zonder J. Myonecrosis in sickle cell anemia-overlooked and underdiagnosed. Case Rep Med. 2010;659031","DOI":"10.1155\/2010\/659031"},{"key":"768_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.12659\/AJCR.900538","volume":"18","author":"LP Turaga","year":"2017","unstructured":"Turaga LP, Boddu P, Kipferl S, Basu A, Yorath M. Myonecrosis in sickle cell Anemia: case study. Am J Case Rep. 2017;18:100\u20133.","journal-title":"Am J Case Rep"},{"key":"768_CR57","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3899\/jrheum.100667","volume":"38","author":"C Toly-Ndour","year":"2011","unstructured":"Toly-Ndour C, Rouquette A-M, Obadia S, M\u2019bappe P, Lionnet F, Hagege I, et al. High titers of autoantibodies in patients with sickle-cell disease. J Rheumatol. 2011;38:302\u20139.","journal-title":"J Rheumatol"},{"key":"768_CR58","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12969-017-0221-x","volume":"16","author":"V Li-Thiao-Te","year":"2018","unstructured":"Li-Thiao-Te V, Uettwiller F, Quartier P, Lacaille F, Bader-Meunier B, Brousse V, et al. Coexistent sickle-cell anemia and autoimmune disease in eight children: pitfalls and challenges. Pediatr Rheumatol. 2018;16:5.","journal-title":"Pediatr Rheumatol"},{"key":"768_CR59","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/pbc.24796","volume":"61","author":"C Dampier","year":"2014","unstructured":"Dampier C, Ely B, Brodecki D, Coleman C, Aertker L, Sendecki JA, et al. Pain characteristics and age-related pain trajectories in infants and young children with sickle cell disease. Pediatr Blood Cancer. 2014;61:291\u20136.","journal-title":"Pediatr Blood Cancer"},{"key":"768_CR60","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/bjhp.12157","volume":"21","author":"B Coleman","year":"2016","unstructured":"Coleman B, Ellis-Caird H, McGowan J, Benjamin MJ. How sickle cell disease patients experience, understand and explain their pain: an interpretative phenomenological analysis study. Br J Health Psychol. 2016;21:190\u2013203.","journal-title":"Br J Health Psychol"},{"key":"768_CR61","doi-asserted-by":"crossref","unstructured":"Karafin MS, Singavi A, Hussain J, Wandersee N, Heinrich T, Hurley RW, et al. Predictive factors of daily opioid use and quality of life in adults with sickle cell disease. Hematology. 2018:1\u20138.","DOI":"10.1080\/10245332.2018.1479997"},{"key":"768_CR62","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1182\/blood-2017-05-782003","volume":"130","author":"H Tran","year":"2017","unstructured":"\u2022 Tran H, Gupta M, Gupta K. Targeting novel mechanisms of pain in sickle cell disease. Blood. 2017;130:2377\u201385. A recent review examining targeting novel mechanisms of pain in SCD.","journal-title":"Blood"},{"key":"768_CR63","doi-asserted-by":"publisher","unstructured":"Brandalise SR, Assis R, ABA Laranjeira, Yunes JA, PO de Campos-Lima. Low-dose methotrexate in sickle-cell disease: a pilot study with rationale borrowed from rheumatoid arthritis. Exp Hematol Oncol. 2017;6:18. \n                      https:\/\/doi.org\/10.1186\/s40164-017-0078-1","DOI":"10.1186\/s40164-017-0078-1"},{"key":"768_CR64","doi-asserted-by":"publisher","first-page":"E314","DOI":"10.1002\/ajh.24365","volume":"91","author":"JA Guy","year":"2016","unstructured":"\u2022 Guy JA, Stallworth JR, Knight LM, Wang Y, Mathews CG, Jerrell JM. Factors associated with musculoskeletal injuries in children and adolescents with sickle cell disease. Am J Hematol. 2016;91:E314\u20136. A study exploring the factors associated with MSK injuries in children and adolescents with SCD.","journal-title":"Am J Hematol"},{"key":"768_CR65","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.bcmd.2015.08.004","volume":"55","author":"A Baldan","year":"2015","unstructured":"\u2022 Baldan A, Giusti A, Bosi C, Malaventura C, Musso M, Forni GL, et al. Klotho, a new marker for osteoporosis and muscle strength in \u03b2-thalassemia major. Blood Cells Mol Dis. 2015;55:396\u2013401. A study exploring Klotho as a novel potential biomarker of rheumatic complications in patients with \u03b2-thalassemia major.","journal-title":"Blood Cells Mol Dis"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-018-0768-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-018-0768-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-018-0768-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T23:17:18Z","timestamp":1565738238000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-018-0768-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,14]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["768"],"URL":"https:\/\/doi.org\/10.1007\/s11926-018-0768-7","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,14]]},"assertion":[{"value":"14 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The author declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"61"}}